enGene Holdings Inc. (ENGN)
NASDAQ: ENGN · IEX Real-Time Price · USD
8.99
+0.04 (0.45%)
At close: Jul 19, 2024, 12:00 AM
9.01
+0.02 (0.22%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
enGene Holdings Employees
As of October 31, 2023, enGene Holdings had 33 total employees, including 31 full-time and 2 part-time employees.
Employees
33
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,493,364
Market Cap
397.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Oct 31, 2023 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Organogenesis Holdings | 862 |
| Cerus | 637 |
| Revance Therapeutics | 597 |
| uniQure | 480 |
| AxoGen | 428 |
| Lyell Immunopharma | 224 |
| Sight Sciences | 214 |
| Precigen | 202 |
ENGN News
- 5 weeks ago - enGene Reports Second Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 7 weeks ago - enGene to Present at the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors - Business Wire
- 2 months ago - enGene to Present Details of its Pivotal Phase 1/2 LEGEND Study of EG-70 in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in situ at the American Urology Association 2024 Annual Meeting - PRNewsWire
- 3 months ago - /C O R R E C T I O N -- enGene Inc./ - PRNewsWire
- 3 months ago - enGene Announces Hiring of Dr. Raja Ruth as Senior Vice President, Urologic Oncology and Clinical Development - PRNewsWire
- 4 months ago - enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress - PRNewsWire
- 4 months ago - enGene To Present at the Leerink Partners Global Biopharma Conference - PRNewsWire